You are here

Press Releases from AlphaMed Press

Comment

Discuss

Embargo Policy: Articles for STEM CELLS and STEM CELLS Translational Medicine are embargoed for release until 9 a.m. Eastern U.S. time on the day the article is posted online. This policy applies to members of the media, authors, institutions' public information officers, and the public. Authors may not discuss their work with the media until 1 week before the mailing date or 1 week before online posting of the article, whichever is earlier, and must ensure that the media representatives agree to abide by the embargo policy. STEM CELLS Translational Medicine may refuse to publish a manuscript, despite acceptance for publication, if it has been prematurely released to the press.

September 3, 2015

Durham, NC, Sep. 3, 2015 /PRNewswire-iReach/ -- According to a study released in the latest issue of STEM CELLS Translational Medicine, a German team of researchers discovered that extracellular vesicles (EVs), tiny membrane-enclosed structures that travel between cells, seem to work as well as adult stem cells to help the brain recover from a stroke.

August 27, 2015

Durham, NC, Aug. 27, 2015 /PRNewswire-iReach/ -- A new study appearing in STEM CELLS Translational Medicine indicates that stem cell injections helped rats live almost a third longer than normal. In addition, the treated animals remained both physically and mentally active longer throughout their life spans.

August 4, 2015

DURHAM, N.C., Aug. 3, 2015 /PRNewswire-iReach/ -- A study released today in STEM CELLS Translational Medicine shows the promise of stem cells for growing new cartilage to replace the tissue damaged by osteoarthritis or injury. That's good news for the rapidly growing number of people undergoing knee and hip replacements each year – nearly a million (645,000 hips and 300,000 knees) in the U.S. alone, according to a 2011 report from the American Academy of Orthopaedic Surgeons.

July 28, 2015

DURHAM, N.C., July 27, 2015 /PRNewswire-iReach/ -- A new clinical trial to test how a high dose of stem cells delivered via a method called "retrograde coronary sinus infusion" affects end stage heart failure patients is showing promising results. The method involves giving the cells backwards (retrograde) through the heart through the main vein (the coronary sinus).  

June 24, 2015

DURHAM, N.C., June 23, 2015 /PRNewswire-iReach/ -- To date, the only definitive treatment for heart failure – an organ transplant – is hampered by both the limited number of organ donors and the potential for the patient's body to reject the new heart.  However, findings of a study published in STEM CELLS Translational Medicine demonstrate the promise in regenerating cardiac tissue using engineered patches made up of a mixture of fibrin and mesenchymal stem cells (MSCs) derived from human umbilical cord blood.

May 29, 2015

DURHAM, N.C., May 29, 2015 /PRNewswire-iReach/ -- A study released today in STEM CELLS Translational Medicine could open the door to a new therapy to potentially expand the current window of time for treating patients after they have experienced a stroke (five times beyond that of a clot-busting drug) and significantly improves their chance of recovery.

May 29, 2015

DURHAM, N.C., May. 27, 2015 /PRNewswire-iReach/ -- A new study appearing today in STEM CELLS Translational Medicine, designed to test how stem cell injections affect primates with spinal cord injury (SCI), showed the treatments significantly improved the animals' motor function recovery and promoted faster healing, too. The researchers call their findings a step forward toward the goal of improving outcomes for humans with chronic SCI. 

April 29, 2015

DURHAM, N.C., May. 1, 2015 /PRNewswire-iReach/ --  Stem cells are a safe therapy for patients with amyotrophic lateral sclerosis (ALS), according to the results of a recently completed phase 1 clinical trial. Details of the trial, conducted by scientists in South Korea, are published in this month's issue of STEM CELLS Translational Medicine.

March 31, 2015

DURHAM, NC (PRWEB) March 31, 2015 /PRWeb/ --  Stem cells may provide Crohn’s disease sufferers relief from a common, potentially dangerous side effect – fistulas – according to the results of a phase 2 clinical trial published in the latest issue of STEM CELLS Translational Medicine (SCTM). After receiving an injection of their own adipose-derived stem cells (ASC), which are collected from fat tissue, the fistulas in 75 percent of the trial participants were completely healed within eight weeks of their last treatment and remained so two years later.

March 25, 2015

DURHAM, NC (PRWEB) March 19, 2015 /PRWeb/ -- A new study appearing in STEM CELLS Translational Medicine has moved science one step closer to finding a simple treatment for erectile dysfunction (ED) after prostate cancer surgery, eschewing the usual pharmaceutical drug route with potential for harmful side effects, in favor of stem cell therapy that can help the body regenerate.

The study, conducted in rats, compares the effectiveness of using a byproduct of liposuction — uncultured stromal vascular fraction (SVF) — with adipose-derived stem cells (ADSCs) cultured in the lab to treat ED caused by injury to the cavernous nerve (CN). This nerve, which facilities erection, is sometimes injured during a radical prostatectomy to treat prostate cancer.

Pages